Neurotrope, Inc.
Pharmaceutical company · New York, United States
Neurotrope, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2016.
Neurotrope at a glance
What does Neurotrope do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $24.5 million sold (2016).
Frequently asked questions about Neurotrope
Where is Neurotrope headquartered?
Neurotrope, Inc. is headquartered in New York, United States.
What does Neurotrope do?
Neurotrope, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Neurotrope founded?
The earliest incorporation on record for Neurotrope, Inc. is in 2013, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences